Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
Abstract Plasma and serum are rich sources of information regarding an individual's health state, and protein tests inform medical decision making. Despite major investments, few new biomarkers have reached the clinic. Mass spectrometry (MS)‐based proteomics now allows highly specific and quant...
Saved in:
| Main Authors: | Philipp E Geyer, Eugenia Voytik, Peter V Treit, Sophia Doll, Alisa Kleinhempel, Lili Niu, Johannes B Müller, Marie‐Luise Buchholtz, Jakob M Bader, Daniel Teupser, Lesca M Holdt, Matthias Mann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2019-09-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201910427 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Revisiting biomarker discovery by plasma proteomics
by: Philipp E Geyer, et al.
Published: (2017-09-01) -
Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
by: Lili Niu, et al.
Published: (2019-03-01) -
Dynamic human liver proteome atlas reveals functional insights into disease pathways
by: Lili Niu, et al.
Published: (2022-05-01) -
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
by: Philipp E Geyer, et al.
Published: (2021-07-01) -
Mass spectrometry‐based proteomics for biomarker discovery in the Drosophila model of Parkinson's disease
by: Mohammad Radid Khan, et al.
Published: (2024-12-01)